
LeMaitre Vascular
A provider of devices, implants and services for the treatment of peripheral vascular disease.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor | €0.0 | round |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
* | N/A | $150m | Post IPO Convertible |
Total Funding | 000k |

USD | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% growth | 19 % | 5 % | 20 % | 14 % | 12 % | 9 % | 10 % |
EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% EBITDA margin | 24 % | 19 % | 26 % | 30 % | 28 % | 29 % | 31 % |
Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% profit margin | 17 % | 13 % | 16 % | 20 % | 20 % | 21 % | 21 % |
EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
R&D % of revenue | 8 % | 8 % | 9 % | 7 % | - | - | - |
Source: Company filings or news article, Equity research estimates
Related Content
LeMaitre is a global provider of innovative medical devices designed specifically for vascular surgeons. The company operates in the healthcare sector, focusing on the treatment of peripheral vascular disease. LeMaitre's core product, the LeMaitre Valvulotome, has significantly improved the treatment of lower extremity arterial disease by allowing surgeons to cut valves in peripheral veins without the need for direct vision. This innovation has led to the saving of 180,000 legs over the past decade.
LeMaitre serves a diverse range of clients, including hospitals, clinics, and specialized vascular surgery centers across 90 countries. The company's business model revolves around the research, development, and sale of high-quality vascular devices. Revenue is generated through the direct sale of these devices to healthcare providers and through distribution agreements in various regions.
The company has expanded its product portfolio to include aortic polyester vascular grafts, vascular allografts, occlusion catheters, AV access systems, collagen vascular grafts, and more. This diverse range of products ensures that LeMaitre can meet various needs within the vascular surgery field.
LeMaitre's commitment to innovation and quality has established it as a trusted name among vascular surgeons worldwide. The company's ongoing research and development efforts aim to further enhance the effectiveness and efficiency of vascular treatments.
Keywords: vascular surgery, medical devices, peripheral vascular disease, LeMaitre Valvulotome, healthcare innovation, aortic grafts, occlusion catheters, AV access, global provider, vascular allografts.
Tech stack
Investments by LeMaitre Vascular
Edit


